HomeCompareZOM vs SBUX

ZOM vs SBUX: Dividend Comparison 2026

ZOM yields 2055.50% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZOM wins by $12828287194.85M in total portfolio value
10 years
ZOM
ZOM
● Live price
2055.50%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12828287195.01M
Annual income
$11,707,825,857,181,476.00
Full ZOM calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — ZOM vs SBUX

📍 ZOM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZOMSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZOM + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZOM pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZOM
Annual income on $10K today (after 15% tax)
$174,717.37/yr
After 10yr DRIP, annual income (after tax)
$9,951,651,978,604,254.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, ZOM beats the other by $9,951,651,978,543,788.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZOM + SBUX for your $10,000?

ZOM: 50%SBUX: 50%
100% SBUX50/50100% ZOM
Portfolio after 10yr
$6414143597.59M
Annual income
$5,853,912,928,626,306.00/yr
Blended yield
91.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ZOM
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-0.0
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZOM buys
0
SBUX buys
0
No recent congressional trades found for ZOM or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZOMSBUX
Forward yield2055.50%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$12828287195.01M$167.0K
Annual income after 10y$11,707,825,857,181,476.00$71,136.45
Total dividends collected$12748926998.50M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: ZOM vs SBUX ($10,000, DRIP)

YearZOM PortfolioZOM Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$216,250$205,549.85$11,121$420.68+$205.1KZOM
2$4,385,604$4,154,217.05$12,548$648.40+$4.37MZOM
3$83,429,631$78,737,034.33$14,440$1,013.98+$83.42MZOM
4$1,489,134,673$1,399,864,967.60$17,068$1,617.30+$1489.12MZOM
5$24,944,940,636$23,351,566,535.79$20,912$2,649.52+$24944.92MZOM
6$392,269,666,568$365,578,580,087.90$26,875$4,499.29+$392269.64MZOM
7$5,792,510,495,062$5,372,781,951,834.12$36,771$8,014.12+$5792510.46MZOM
8$80,345,661,782,925$74,147,675,553,208.94$54,542$15,197.11+$80345661.73MZOM
9$1,047,160,128,816,172$961,190,270,708,442.20$89,602$31,242.49+$1047160128.73MZOM
10$12,828,287,195,014,780$11,707,825,857,181,476.00$167,011$71,136.45+$12828287194.85MZOM

ZOM vs SBUX: Complete Analysis 2026

ZOMStock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

Full ZOM Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ZOM vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZOM vs SCHDZOM vs JEPIZOM vs OZOM vs KOZOM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.